Trial record 1 of 1 for:    CA220-008
Previous Study | Return to List | Next Study

Safety Study of IL-21/Anti-PD-1 Combination in the Treatment of Solid Tumors

This study has been completed.
Information provided by (Responsible Party):
Bristol-Myers Squibb Identifier:
First received: June 26, 2012
Last updated: March 5, 2015
Last verified: February 2015
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: December 2014
  Primary Completion Date: December 2014 (Final data collection date for primary outcome measure)